Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,600 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia.
Italian Cooperative Study Group on Chronic Myeloid Leukemia; Tura S, Baccarani M, Zuffa E, Russo D, Fanin R, Zaccaria A, Fiacchini M. Italian Cooperative Study Group on Chronic Myeloid Leukemia, et al. Among authors: russo d. N Engl J Med. 1994 Mar 24;330(12):820-5. doi: 10.1056/NEJM199403243301204. N Engl J Med. 1994. PMID: 8114834 Free article. Clinical Trial.
Pregnancy and abortion in women with essential thrombocythemia.
Candoni A, Fanin R, Michelutti T, Russo D, Michelutti A. Candoni A, et al. Among authors: russo d. Am J Hematol. 2002 Mar;69(3):233-4. doi: 10.1002/ajh.10068. Am J Hematol. 2002. PMID: 11891817 Free article. No abstract available.
Rituximab for the treatment of type II mixed cryoglobulinemia.
Zaja F, De Vita S, Russo D, Michelutti A, Fanin R, Ferraccioli G, Baccarani M. Zaja F, et al. Among authors: russo d. Arthritis Rheum. 2002 Aug;46(8):2252-4; author reply 2254-5. doi: 10.1002/art.10345. Arthritis Rheum. 2002. PMID: 12209536 Free article. No abstract available.
Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target?
Malagola M, Martinelli G, Rondoni M, Paolini S, Gaitani S, Arpinati M, Piccaluga PP, Amabile M, Basi C, Ottaviani E, Candoni A, Gottardi E, Cilloni D, Bocchia M, Saglio G, Lauria F, Fanin R, Visani G, Marrè MC, Maderna M, Rancati F, Vinaccia V, Russo D, Baccarani M. Malagola M, et al. Among authors: russo d. Blood. 2005 Jan 15;105(2):904; author reply 905. doi: 10.1182/blood-2004-08-3088. Blood. 2005. PMID: 15632213 Free article. No abstract available.
Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients.
Russo D, Malagola M, de Vivo A, Fiacchini M, Martinelli G, Piccaluga PP, Damiani D, Candoni A, Michielutti A, Castelli M, Testoni N, Ottaviani E, Rondoni M, Pricolo G, Mazza P, Zuffa E, Zaccaria A, Raspadori D, Bocchia M, Lauria F, Bonini A, Avanzini P, Gugliotta L, Visani G, Fanin R, Baccarani M. Russo D, et al. Br J Haematol. 2005 Oct;131(2):172-9. doi: 10.1111/j.1365-2141.2005.05745.x. Br J Haematol. 2005. PMID: 16197446 Free article. Clinical Trial.
1,600 results